Edgewise Begins New Observational Trial

We are pleased to share that Edgewise Therapeutics is sponsoring a natural history study in Becker muscular dystrophy, to better understand the course of disease and define endpoints to be used in future clinical trials.  The observational study will follow 150 individuals, ages 8 and older, over two years at multiple sites in the US and Europe.

More information is available in the press release below.